Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2026-03-06 @ 6:02 PM
Study NCT ID:
NCT02465658
Status:
UNKNOWN
Last Update Posted:
2015-12-16
First Post:
2015-06-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Risk Factors for Co-existence of Cervical Elongation in Uterine Prolapse
Sponsor:
National Taiwan University Hospital
Organization:
Study Overview
Official Title:
Risk Factors for Co-existence of Cervical Elongation in Uterine Prolapse
Status:
UNKNOWN
Status Verified Date:
2015-12
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The presence of co-existence of cervical elongation in women of uterine prolapse may decrease the patients' satisfaction of uterine-preservation surgery for uterine prolapse, and additional surgery, such as Manchester surgery, may be needed to solve the problem.Thus the aim of this study is to investigate the risk factors of co-existence of cervical elongation in uterine prolapse.
Detailed Description:
Purpose:
Thus the aim of this study is to investigate the risk factors of co-existence of cervical elongation in uterine prolapse.
Patients and Methods:
Between January 1994 and October 2014, all women underwent vaginal total hysterectomy in a medical center were enrolled in this study. Medical records were reviewed. Cervical elongation is defined as the presence of cervical length \>3.38 cm or cervix to corpus ratio \>0.79.
Expected Results:
The investigators will get the risk factors of co-existence of cervical elongation in uterine prolapse, and the result should be helpful for preoperative consultation, especially for uterine-preserving pelvic floor reconstruction surgery.
Thus the aim of this study is to investigate the risk factors of co-existence of cervical elongation in uterine prolapse.
Patients and Methods:
Between January 1994 and October 2014, all women underwent vaginal total hysterectomy in a medical center were enrolled in this study. Medical records were reviewed. Cervical elongation is defined as the presence of cervical length \>3.38 cm or cervix to corpus ratio \>0.79.
Expected Results:
The investigators will get the risk factors of co-existence of cervical elongation in uterine prolapse, and the result should be helpful for preoperative consultation, especially for uterine-preserving pelvic floor reconstruction surgery.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: